OR WAIT null SECS
© 2022 MJH Life Sciences and Contemporary Pediatrics. All rights reserved.
© 2022 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
August 02, 2022
If approved, ibrexafungerp would be the first and only approved therapy for both the treatment of vulvovaginal candidiasis (VVC) and the prevention of recurrent vulvovaginal candidiasis (RVVC).
July 27, 2022
This decision by the US Food and Drug Administration marks the first approved treatment for pediatric lupus nephritis.
July 26, 2022
What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.
July 20, 2022
VIVUS LLC announced the US Food and Drug Administration's approval of QSYMIA (phentermine and topiramate extended-release capsules) for the treatment of obesity in adolescents ages 12 to 17 years.
The approval represents an adjunctive therapy option for pediatric patients older than age 16, as well as adults.
July 19, 2022
If approved, trofinetide has the potential to be a new treatment for Rett syndrome in pediatric and adult patients 2 years and older.
Opzelura (ruxolitinib) cream is the first and only FDA-approved treatment for adult and pediatric patients 12 years of age or older with vitiligo.
July 18, 2022
Nonstimulant drugs and even nonmedication options are available for use.
July 07, 2022
Cynthia J. Trickett, PA-C, MPAS, discusses the personal and clinical effects of atopic dermatitis in adult and pediatric patients at the 2022 Maui Dermatology Conference for PAs & NPs.
June 29, 2022
Ruling comes in cases of physicians serving in prison for convictions over prescription drugs.